Sofia Genta
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 19
- Cancer Immunotherapy and Biomarkers 9
- PARP inhibition in cancer therapy 4
- CAR-T cell therapy research 2
- Cutaneous Melanoma Detection and Management 2
-
- Ovarian cancer diagnosis and treatment 4
- Co-authors
- Giorgio Valabrega (13 shared papers)Eleonora Ghisoni (10 shared papers)Gaia Giannone (9 shared papers)Gloria Mittica (10 shared papers)Massimo Aglietta (7 shared papers)Lillian L. Siu (4 shared papers)Abi Vijenthira (1 shared paper)Jesús Fuentes‐Antrás (1 shared paper)
- Journals
- Clinical Cancer Research (4 papers)Annals of Oncology (4 papers)International Journal of Molecular Sciences (3 papers)Oncotarget (2 papers)Recent Patents on Anti-Cancer Drug Discovery (1 paper)
- Partner nations
- CanadaItalySwitzerland
In The Last Decade
Sofia Genta
33 papers receiving 905 citations
Sofia Genta's Hit Papers
Peers
Comparison fields: 5 of 57
- Oncology 378
- Reproductive Medicine 102
- Obstetrics and Gynecology 66
- Drug Discovery 2
- Cancer Research 80
Countries citing papers authored by Sofia Genta
This map shows the geographic impact of Sofia Genta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia Genta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia Genta more than expected).
Fields of papers citing papers by Sofia Genta
This network shows the impact of papers produced by Sofia Genta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia Genta. The network helps show where Sofia Genta may publish in the future.
Co-authors
The 25 scholars most cited alongside Sofia Genta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antibody–drug conjugates: in search of partners of choice Hit paper breakdown → | 2023 | 163 |
| 2 | 2018 | 126 | |
| 3 | 2020 | 124 | |
| 4 | 2017 | 92 | |
| 5 | 2023 | 58 | |
| 6 | 2016 | 57 | |
| 7 | 2021 | 31 | |
| 8 | 2019 | 27 | |
| 9 | 2022 | 26 | |
| 10 | 2019 | 24 | |
| 11 | 2024 | 23 | |
| 12 | 2018 | 19 | |
| 13 | 2022 | 17 | |
| 14 | 2021 | 16 | |
| 15 | 2017 | 14 | |
| 16 | 2019 | 12 | |
| 17 | 2021 | 12 | |
| 18 | 2021 | 12 | |
| 19 | 2020 | 11 | |
| 20 | 2023 | 11 |
About Sofia Genta
Sofia Genta is a scholar working on Oncology, Reproductive Medicine, Cancer Research, Molecular Biology and Obstetrics and Gynecology, having authored 33 papers that have together received 933 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Ovarian cancer diagnosis and treatment (4 papers), PARP inhibition in cancer therapy (4 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Advanced Breast Cancer Therapies (2 papers), CAR-T cell therapy research (2 papers), Cancer Genomics and Diagnostics (2 papers) and Cutaneous Melanoma Detection and Management (2 papers). The work is most often cited by research in Oncology (378 citations), Reproductive Medicine (102 citations), Obstetrics and Gynecology (66 citations), Drug Discovery (2 citations) and Cancer Research (80 citations). Sofia Genta has collaborated with scholars based in Canada, Italy and Switzerland. Frequent co-authors include Giorgio Valabrega, Eleonora Ghisoni, Gaia Giannone, Gloria Mittica, Massimo Aglietta, Lillian L. Siu, Abi Vijenthira, Jesús Fuentes‐Antrás, Giulia Scotto and Valentina Tuninetti. Their work appears in journals such as Clinical Cancer Research, Annals of Oncology, International Journal of Molecular Sciences, Oncotarget and Recent Patents on Anti-Cancer Drug Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.